Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading international provider of consumer cannabis products, today announced the launch of adult-use sales at its Bordentown, New Jersey location. Curaleaf Bordentown, located at 191 Route 130, is the Company’s third and final location to sell adult-use cannabis in the Garden State.
Curaleaf is committed to providing premium quality products and reliable retail experiences for adult-use consumers while continuing to serve patients enrolled in the state’s medical program. Curaleaf Bordentown will continue to prioritize New Jersey’s licensed medical patients by providing private consultation areas, a secure online ordering system, exclusive checkout lines and designated parking spots. To optimize patient accessibility, Curaleaf Bordentown offers medical patient exclusive shopping hours every day from 8 a.m. to 9 a.m. and 7 p.m. to 8 p.m.
“We are thrilled to expand adult-use sales to Curaleaf Bordentown, which now allows us to serve both medical and adult-use customers across our entire New Jersey footprint,” said Matt Darin, CEO of Curaleaf. “Curaleaf is committed to ensuring our patients and consumers receive quality products and service as they embark on their cannabis journey. We’d like to thank the City of Bordentown for their continued partnership and for welcoming us into the community.”
According to the New Jersey Cannabis Regulatory Commission, the state generated more than $79 million in recreational cannabis sales from April 21 to June 30. Tax revenue in this period totaled $4.6 million.
Curaleaf Bordentown offers adult-use customers a wide variety of innovative products including Select Squeeze, a fast-acting THC beverage enhancer, as well as Select’s best-selling Elite and Elite Live oil. The Company’s New Jersey offerings have also recently expanded to include B NOBLE two-pack pre-rolls.
For more information on the Curaleaf’s locations, patient resources and products in New Jersey, please visit www.curaleaf.com/dispensary/new-jersey.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 21 states with 142 dispensaries, 26 cultivation sites, and employs over 6,000 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
